Hermetica Superfood Encyclopedia
The Short Answer
Sea cucumber peptides are small-molecule collagen-derived polypeptides (<2–5 kDa) produced by enzymatic hydrolysis that exert antioxidant, antihypertensive, anticancer, and neuroprotective effects by scavenging reactive oxygen species, inhibiting ACE, and modulating PI3K/AKT and PKA/BDNF/NGF signaling pathways. The tetrapeptide FPTY demonstrates particularly potent activity with an IC50 of 0.11 ± 0.01 mg/mL for hydroxyl radical scavenging and 0.03 ± 0.01 mg/mL for ACE inhibition in vitro, rivaling the binding profile of the pharmaceutical drug lisinopril in molecular docking studies.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordsea cucumber peptides benefits
Sea Cucumber Peptides — botanical close-up
Health Benefits
**Antioxidant Protection**
Peptides such as FPTY and fractions from Cucumaria frondosa scavenge hydroxyl radicals, DPPH, and superoxide anions while upregulating endogenous antioxidant enzymes SOD and GSH-Px, reducing systemic oxidative stress in animal models of aging.
**Antihypertensive Activity**
Multiple identified peptides inhibit angiotensin-converting enzyme (ACE) with IC50 values ranging from 0.05 to 1.71 mmol/L; molecular docking confirms FPTY binds the ACE active site analogously to the clinical drug lisinopril, suggesting a pharmacologically relevant mechanism.
**Anticancer Potential**
Intestinal peptide fractions below 1 kDa from sea cucumbers suppress MCF-7 breast cancer cell proliferation by inhibiting the PI3K/AKT signaling pathway and upregulating pro-apoptotic proteins, with activity confirmed in zebrafish tumor models.
**Neuroprotection and Cognitive Support**
The heptapeptide NDEELNK (860 Da) from Stichopus japonicus enhances PKA/BDNF/NGF signaling, increases acetylcholine (ACh) levels, and modulates AChE activity in PC12 neuronal cells, indicating potential utility in age-related cognitive decline.
**Antihyperuricaemic Effects**
Hexapeptides GPAGPR and GPSGRP inhibit uric acid biosynthesis and reabsorption, with additional modulation of gut microbiota composition and host miRNA expression, positioning these peptides as candidates for gout management support.
**Anti-Fatigue and Mitochondrial Support**
Sea cucumber peptides upregulate mRNA and protein expression involved in mitochondrial biogenesis and gluconeogenesis in C57BL/6J mice, reducing exercise-induced fatigue markers and supporting energy metabolism.
**Anti-Aging and Longevity Signaling**
Peptides from Stichopus variegatus promote longevity and reduce D-galactose-induced oxidative injury in fruit fly and mouse aging models by upregulating Klotho, SOD, and GSH-Px expression, implicating modulation of aging-associated signaling cascades.
Origin & History
Natural habitat
Sea cucumbers (class Holothuroidea) are marine echinoderms distributed globally across ocean floors, with commercially significant species including Stichopus japonicus (Japanese sea cucumber) native to the Northwest Pacific, Cucumaria frondosa (Atlantic), and Parastichopus californicus (Pacific Coast of North America). They are harvested both wild from coastal seabeds and through aquaculture systems, particularly in China, Japan, and South Korea, where S. japonicus has been cultivated for centuries. Bioactive peptides are not naturally isolated in the living animal but are produced post-harvest through controlled enzymatic hydrolysis of the body wall, intestines, and gonads, which are rich in marine collagen.
“Sea cucumbers have been consumed as a prized tonic food in East Asian cultures for over a millennium, particularly in China, Japan, and South Korea, where species such as Stichopus japonicus (known as 'namako' in Japanese and 'haishen' in Chinese) were considered luxury health foods associated with longevity, vitality, and kidney-tonifying properties in traditional Chinese medicine (TCM). Historical TCM texts reference sea cucumber as a 'warm' and 'salty' food that nourishes jing (essence) and blood, recommended for fatigue, sexual debility, and general weakness — traditional indications that partially overlap with the modern preclinical evidence for anti-fatigue and antioxidant effects. Preparation traditionally involved sun-drying harvested animals followed by prolonged rehydration and slow braising or stewing in rich broths, a process that partially hydrolyzes structural collagen into shorter peptides accessible for absorption. The modern scientific interest in isolating specific bioactive peptides via enzymatic hydrolysis represents a technological extension of these traditional practices, shifting from whole-food consumption to concentrated, fractionated bioactive preparations.”Traditional Medicine
Scientific Research
The current evidence base for sea cucumber peptides consists entirely of in vitro cell-culture studies, animal studies (mice, rats, zebrafish, and Drosophila melanogaster), and computational molecular docking analyses; no published human clinical trials with defined sample sizes, randomization, or quantified effect sizes have been identified as of the knowledge cutoff. In vitro findings are mechanistically detailed — for example, FPTY demonstrates ACE IC50 of 0.03 ± 0.01 mg/mL and hydroxyl radical scavenging IC50 of 0.11 ± 0.01 mg/mL — but these concentrations are achieved under controlled laboratory conditions that do not account for gastrointestinal digestion, absorption, or systemic bioavailability in humans. Animal studies using C57BL/6J mice, D-galactose-induced aging models, and zebrafish xenograft tumor assays report statistically positive outcomes for anti-fatigue, anti-aging, and anticancer endpoints, but sample sizes, randomization methods, and blinding protocols are not consistently reported in available literature summaries. While the mechanistic plausibility is scientifically sound given the known bioactivity of marine collagen-derived peptides, the absence of human pharmacokinetic data, dose-response curves in vivo, and randomized controlled trials means the clinical translation of these findings remains entirely unestablished.
Preparation & Dosage
Traditional preparation
**Enzymatic Hydrolysate Powder**
The primary commercial and research form; produced by digesting sea cucumber body walls, intestines, or gonads with alkaline protease or commercial protease blends, then fractionating via ultrafiltration to isolate peptides <2–5 kDa. No standardized human dose established.
**Ultrafiltration Fractions (<1 kDa, 1–3 kDa, 3–5 kDa)**
Research preparations separated by molecular weight cutoff membranes; the <1 kDa intestinal peptide fraction shows the highest anticancer activity in vitro. Not commercially standardized.
**Sephadex/HPLC-Purified Peptides**
Research-grade isolated peptides (e.g., FPTY, NDEELNK, GPAGPR) purified by size-exclusion chromatography and reversed-phase HPLC for mechanistic studies; not available as consumer supplements.
**Traditional Whole Sea Cucumber (Dried/Reconstituted)**
Consumed in East Asian cuisine as a protein-rich food; collagen peptides are partially released during cooking and digestion but bioactive fragment profile is uncontrolled.
**Effective Dose Range**
No human effective dose has been established. In vitro IC50 values and animal studies use weight-based dosing (mg/kg) not translatable to standard human supplement doses without pharmacokinetic data.
**Timing Notes**
Preclinical anti-fatigue studies administered peptides prior to exercise challenge; no human timing optimization data exists.
Nutritional Profile
Sea cucumber body walls are approximately 70% collagen by dry weight, making them one of the richest marine sources of fibrillar collagen, predominantly types I and II with unique hydroxylated and glycosylated amino acid residues including hydroxyproline and hydroxylysine. The whole dried sea cucumber is high in protein (40–60% dry weight), very low in fat (<5%), contains glycosaminoglycans (chondroitin sulfate, fucosylated chondroitin sulfate), and provides micronutrients including calcium, magnesium, zinc, and selenium. Enzymatically hydrolyzed peptide fractions are enriched in small-molecule collagen-derived peptides (<5 kDa) with high proportions of glycine, proline, hydroxyproline, and alanine residues characteristic of marine collagen; these small peptides are theoretically more bioavailable than intact collagen due to reduced molecular size, though quantitative human absorption studies are not available. Bioavailability of specific peptides is likely influenced by gastrointestinal proteolytic stability, with sub-2 kDa fractions generally considered to resist further degradation and reach systemic circulation intact, though this has not been confirmed with human pharmacokinetic studies.
How It Works
Mechanism of Action
Sea cucumber peptides exert antioxidant effects primarily through direct free radical scavenging of hydroxyl radicals, DPPH, and superoxide anions, and secondarily by transcriptionally upregulating endogenous antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), reducing lipid peroxidation and systemic oxidative burden. Antihypertensive activity is mediated by competitive inhibition of angiotensin-converting enzyme (ACE), with the tetrapeptide FPTY shown via in silico molecular docking to occupy the ACE active site with binding geometry comparable to the pharmaceutical ACE inhibitor lisinopril, blocking conversion of angiotensin I to the vasoconstrictor angiotensin II. Anticancer mechanisms involve suppression of the phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) survival pathway and concurrent upregulation of pro-apoptotic proteins in MCF-7 breast cancer cells, while the heptapeptide NDEELNK activates cAMP-dependent protein kinase A (PKA) and downstream neurotrophic factors BDNF and NGF in neuronal PC12 cells, preserving cholinergic function. The antihyperuricaemic hexapeptides GPAGPR and GPSGRP operate through dual inhibition of xanthine oxidase-mediated uric acid biosynthesis and transporter-mediated renal uric acid reabsorption, with secondary reshaping of gut microbiota and modulation of host regulatory miRNAs involved in purine metabolism.
Clinical Evidence
No human clinical trials evaluating sea cucumber peptides as isolated bioactive compounds have been published in the peer-reviewed literature identified in this review; the entire clinical evidence base is preclinical. Animal and cell-based studies demonstrate meaningful antioxidant, antihypertensive, anticancer, anti-aging, and neuroprotective effects with specific molecular endpoints, but none of these outcomes have been measured in human subjects with validated clinical instruments, placebo controls, or statistically powered designs. Outcomes studied preclinically include serum oxidative stress markers (SOD, GSH-Px, MDA), tumor cell viability and apoptosis indices, ACE inhibitory activity, uric acid levels, and behavioral fatigue parameters in rodents. Confidence in the clinical applicability of sea cucumber peptides is therefore low; they should currently be regarded as a scientifically promising but clinically unvalidated functional food ingredient requiring Phase I and Phase II human trials before therapeutic claims can be substantiated.
Safety & Interactions
Sea cucumber peptides and whole sea cucumber as a food ingredient have no documented toxicity in preclinical studies; animal models and cell studies describe them as safe with high biological activity and strong target specificity, and no adverse effects have been reported at doses used in research. No specific drug interaction data exist for isolated sea cucumber peptides; however, given the documented ACE-inhibitory activity of several peptides (IC50 values 0.03–1.71 mmol/L in vitro), caution is theoretically warranted in individuals taking antihypertensive medications, particularly ACE inhibitors (e.g., lisinopril, enalapril) or angiotensin receptor blockers, as additive blood pressure-lowering effects are biologically plausible. Individuals with shellfish or seafood allergies should exercise caution, as sea cucumber is a marine invertebrate and cross-reactive allergenic proteins may be present in preparations that are not highly purified. No human safety data, maximum tolerated doses, pregnancy or lactation guidance, or pediatric safety assessments exist for isolated sea cucumber peptide preparations, and their use in these populations cannot currently be recommended based on available evidence.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
sea cucumber collagen hydrolysatePeptides from Sea Cucumber (Holothuria scabra, Stichopus japonicus, Actinopyga lecanora, Isostichopus badionotus)haishen peptidesSea Cucumber Peptides (Holothuria scabra)Stichopus japonicus peptidesmarine collagen peptides (holothurian)Holothuroidea hydrolysate
Frequently Asked Questions
What are sea cucumber peptides and how are they made?
Sea cucumber peptides are small-molecule collagen-derived polypeptides (<2–5 kDa) produced by enzymatic hydrolysis of the body wall, intestines, or gonads of sea cucumbers (class Holothuroidea). Commercial proteases or alkaline proteases break down the collagen matrix — which constitutes approximately 70% of sea cucumber structure — and the resulting hydrolysate is fractionated by ultrafiltration and purified by HPLC or Sephadex chromatography to isolate bioactive peptide fractions with specific molecular weight profiles.
What does the research say about sea cucumber peptides for cancer?
Preclinical research shows that intestinal peptide fractions below 1 kDa from sea cucumber inhibit MCF-7 human breast cancer cell proliferation by suppressing the PI3K/AKT cell survival pathway and upregulating pro-apoptotic proteins, with activity confirmed in zebrafish xenograft tumor models. However, no human clinical trials have been conducted, and these findings represent early-stage in vitro and animal evidence only; the anticancer activity of sea cucumber peptides in humans has not been established or validated in any controlled clinical study.
Can sea cucumber peptides lower blood pressure?
In vitro studies demonstrate that multiple sea cucumber peptides inhibit angiotensin-converting enzyme (ACE) with IC50 values ranging from 0.05 to 1.71 mmol/L, with the tetrapeptide FPTY showing the most potent activity (IC50 0.03 ± 0.01 mg/mL) and molecular docking confirming it binds the ACE active site similarly to the pharmaceutical drug lisinopril. While this mechanistic evidence is compelling, no human clinical trials have confirmed blood pressure-lowering effects, and individuals on ACE inhibitor medications should consult a physician before using sea cucumber peptide supplements due to the theoretical risk of additive hypotensive effects.
What is the recommended dosage for sea cucumber peptides?
No standardized human clinical dose for sea cucumber peptides has been established, as no human pharmacokinetic or dose-ranging studies have been published. All bioactivity data derive from in vitro experiments (reporting IC50 values in mg/mL) or animal studies using weight-based dosing (mg/kg) that cannot be directly extrapolated to human supplement dosing without absorption and bioavailability data. Until human clinical trials are conducted, no specific dosage recommendation can be made with scientific confidence.
Are sea cucumber peptides safe to take as a supplement?
Available preclinical data describe sea cucumber peptides as well-tolerated with no observed toxicity in cell culture and animal studies, and whole sea cucumber has a long safety record as a traditional East Asian food ingredient. However, individuals with seafood or shellfish allergies should exercise caution, and those taking antihypertensive drugs (particularly ACE inhibitors) should consult a healthcare provider given the documented ACE-inhibitory activity of specific peptides. Formal human safety data, maximum tolerated doses, and pregnancy/lactation safety assessments do not currently exist for isolated sea cucumber peptide preparations.
Does sea cucumber peptide supplementation interact with ACE inhibitor medications?
Sea cucumber peptides naturally inhibit angiotensin-converting enzyme (ACE), the same target as prescription ACE inhibitor medications used for blood pressure management. Combining sea cucumber peptides with ACE inhibitors like lisinopril or enalapril may potentiate blood pressure-lowering effects and increase hypotension risk. Individuals taking ACE inhibitor medications should consult their healthcare provider before supplementing with sea cucumber peptides to avoid excessive blood pressure reduction.
Which sea cucumber species provides the most potent peptide extract?
Cucumaria frondosa is among the most well-researched species for bioactive peptide content, with studies demonstrating significant antioxidant and ACE-inhibitory activity from its fractionated peptide extracts. Holothurian species vary considerably in peptide composition and potency depending on geographic origin, processing methods, and extraction techniques used during supplement manufacturing. Look for products specifically standardized to peptide fractions or AC-inhibitory activity rather than generic sea cucumber powder, as these indicate higher bioactive compound concentration.
How do sea cucumber peptides compare to other marine peptide supplements for antioxidant protection?
Sea cucumber peptides demonstrate specific radical-scavenging activity against hydroxyl radicals, DPPH, and superoxide anions while upregulating endogenous antioxidant enzymes like SOD and GSH-Px, providing dual antioxidant mechanisms. Unlike simple antioxidant nutrients, sea cucumber peptides stimulate the body's own antioxidant defenses rather than relying solely on exogenous free radical neutralization. This enzymatic upregulation may offer more sustained antioxidant protection in aging models compared to passive antioxidants like vitamin C or E alone.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w sea-cucumber-peptides-holothuroidea-spp curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
